Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
VTv Therapeutics Announces Licensing Agreement for Novel Nrf2 Activator to Anteris Bio
Wednesday, December 16, 2020VTv Therapeutics Inc announced that vTv Therapeutics LLC vTv has entered into a licensing agreement with Anteris Bio for worldwide rights to vTvs novel clinicalstage Nrf activator compound HPP
Ashvattha Therapeutics Announces Collaboration With Stanford University for Preclinical Development of a Novel Neuroimaging Agent, OP-801
Tuesday, December 15, 2020Ashvattha Therapeutics a biotech company focused on developing novel hydroxyl dendrimer therapeutics HDTs to treat unmet medical needs in inflammatory oncology and ocular diseases today announced the initiation of a preclinical proof of concept study...
Teon Therapeutics Announces Approval for Collaboration with Cancer Research UK
Tuesday, December 15, 2020Teon Therapeutics a private biopharmaceutical company developing a focused portfolio of small molecules that modulate metabolic signaling pathways in the tumor microenvironment today announced that Cancer Research UK the worlds leading cancer charity...
Sonoma Pharmaceuticals and Crown Laboratories Announce an Exclusive Partnership to Launch Microcyn® Technology-Based Anti-Itch Over-the-Counter Products
Monday, December 14, 2020Sonoma Pharmaceuticals Inc a global healthcare leader developing and producing high performance stabilized hypochlorous acid HOCl products for a wide range of applications including wound care eye care oral care nasal care and dermatological conditio...
Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion
Friday, December 11, 2020Boehringer Ingelheim today announced the signing of a binding agreement for acquiring all shares of NBETherapeutics a private clinicalstage Swiss biotechnology company focused on antibodydrug conjugates and advancing targeted cancer therapies derived...
Arcus Biosciences Expands Strategic Relationship with WuXi Biologics to Develop a Best-in-Class anti-CD39 Antibody for the Treatment of Cancer
Thursday, December 10, 2020Arcus Biosciences Inc an oncologyfocused biopharmaceutical company working to create bestinclass cancer therapies and WuXi Biologics HK a global company with leading openaccess biologics technology platforms announced an expansion of their existing s...
InveniAI and Kyowa Kirin Enter AI-Powered Novel Target Discovery Collaboration
Thursday, December 10, 2020InveniAI LLC a global leader in pioneering the application of artificial intelligence AI and machine learning ML to transform innovation across drug discovery and development and Kyowa Kirin Co Ltd Kyowa Kirin TSE a global specialty pharmaceutical co...
Applied BioMath, LLC Announces Collaboration with Antengene for Systems Pharmacology Modeling in Oncology
Wednesday, December 09, 2020Applied BioMath wwwappliedbiomathcom the industryleader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development today announced a collaboration with Antengene Corporation for the devel...
Intec Pharma Announces Cannabinoid Research Collaboration with GW Pharma
Wednesday, December 09, 2020Intec Pharma Ltdannounces it has entered into a feasibility agreement with GW Research Limited GW London UK to explore using the Accordion Pill AP platform for an undisclosed research programWe are very excited to collaborate with GW said Jeffrey A M...
Aligos Enters into an Exclusive License and Research Collaboration Agreement with Merck to Discover and Develop an Oligonucleotide Therapy for NASH
Tuesday, December 08, 2020Aligos Therapeutics Incannounced that it has entered into an Exclusive License and Research Collaboration Agreement with Merck known as MSD outside the United States and Canada under which Merck and Aligos will apply Aligos oligonucleotide platform t...
